IMMUNOTECH-B: PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE FOURTH MEMORANDUM AND ARTICLES OF ASSOCIATION
IMMUNOTECH-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
IMMUNOTECH-B: DATE OF BOARD MEETING
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENT THE CLINICAL TRIAL APPROVAL FOR THE aT19 INJECTION
IMMUNOTECH-B: Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
IMMUNOTECH-B: Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE PHASE II CLINICAL TRIAL FOR CAR-T-19 INJECTION
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENT RECEIPT OF THE ACCEPTANCE NOTICE FOR THE INVESTIGATIONAL NEW DRUG APPLICATION FOR THE aT19 INJECTION
IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE PHASE I CLINICAL TRIAL FOR THE DENOCABTAGENE CILOLEUCEL INJECTION
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
IMMUNOTECH-B: 2023 INTERIM REPORT
IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENT EAL WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR TREATMENT OF LIVER CANCER BY THE CENTER FOR DRUG EVALUATION
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
IMMUNOTECH-B: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
IMMUNOTECH-B: APPOINTMENT AND RESIGNATION OF DIRECTORS
No Data